Ann: Letter to IMUOA & IMUOB Option Share Holders, page-13

This is Allan Kohler's interview with IMU CEO. You can try to get full interview from this link: disallowed link/investment-news/imugene-imploding-cancer-cells/148724

Below is a quote related to kates' post:

Leslie, as always with these interviews, let’s start with cash. How much have you got in the bank at the moment and how much are you burning?

We currently have something like $30 million in our coffers, as it were, and we burn – the rate goes higher for when we start the clinical trials because we really like to spend the money on the actual patients and the data collection and running up our clinical trials. And so, we currently have a few studies ongoing. I think we last reported per quarter we burned something like $5 million, but that also includes overheads as well.

Right, I mean, you’re only in phase 2 so you’ll have to raise some more money at some point I guess, won’t you?

Well, probably not because one of the main things about a small biotech company like this is we’re not burdened with the heavy overhead costs and also a lot of companies like mine just simply either get partnered or taken over by big pharma.

Is that on the horizon?

Something that we always look forward to.

[Laughs] Are you talking to people at the moment?

I can’t really say, can I?

No, you can’t, that’s right, but I thought I’d ask.

Too market-sensitive – yes, of course.